Shimba Shigeki, Watabe Yuichi
Department of Health Science, College of Pharmacy, Nihon University, Funabashi, Chiba, Japan.
Biochem Pharmacol. 2009 Feb 15;77(4):560-5. doi: 10.1016/j.bcp.2008.09.040. Epub 2008 Oct 15.
In this chapter, we review the crosstalk between the AHR signaling pathway and molecular clock system in mammals. In mammals, circadian rhythm is observed in most physiological functions including behavior, metabolism, cell growth, and immune responses. Circadian rhythm is regulated by a transcriptional feedback loop, and the transcription factor called "Brain Muscle ARNT-like protein 1 (BMAL1)" is a master regulator of this system. Because of its structural similarity to ARNT, a partner of AHR, BMAL1 is also referred as ARNT3. This structural feature of BMAL1 suggests that the activation of the AHR signaling pathway may influence the regulation of circadian rhythm. Several studies have shown that the expression levels of AHR display diurnal variation in many tissues. This circadian variation of AHR means that the pharmacological effects of AHR agonists vary according to the time of administration. AHR agonist administration results in a disruption of circadian rhythm with regard to behavior, immune cell proliferation, etc. As such, understanding the crosstalk between the AHR signaling and circadian rhythm may provide a new insight into TCDD actions.
在本章中,我们回顾了哺乳动物中芳烃受体(AHR)信号通路与分子时钟系统之间的相互作用。在哺乳动物中,大多数生理功能(包括行为、新陈代谢、细胞生长和免疫反应)都存在昼夜节律。昼夜节律由一个转录反馈环调控,名为“脑肌肉芳香烃受体核转运蛋白样蛋白1(BMAL1)”的转录因子是该系统的主要调节因子。由于BMAL1与AHR的伴侣芳烃受体核转运蛋白(ARNT)结构相似,BMAL1也被称为ARNT3。BMAL1的这一结构特征表明,AHR信号通路的激活可能会影响昼夜节律的调节。多项研究表明,AHR的表达水平在许多组织中呈现昼夜变化。AHR的这种昼夜变化意味着AHR激动剂的药理作用会根据给药时间而有所不同。给予AHR激动剂会导致行为、免疫细胞增殖等方面的昼夜节律紊乱。因此,了解AHR信号与昼夜节律之间的相互作用可能会为2,3,7,8-四氯二苯并对二恶英(TCDD)的作用提供新的见解。